1983
10 Clinical Studies of MHPG in Childhood and Adolescence**The research was supported in part by MHCRC grant MH30929, CCRC grant RR00125, NICHD grant HD-03008, the W. T. Grant Foundation, the MacArthur Foundation, Mr. Leonard Berger, and The Solomon R. & Rebecca D. Baker Foundation, Inc.
YOUNG J, COHEN D, SHAYWITZ B, ANDERSON G, MAAS J. 10 Clinical Studies of MHPG in Childhood and Adolescence**The research was supported in part by MHCRC grant MH30929, CCRC grant RR00125, NICHD grant HD-03008, the W. T. Grant Foundation, the MacArthur Foundation, Mr. Leonard Berger, and The Solomon R. & Rebecca D. Baker Foundation, Inc. 1983, 193-218. DOI: 10.1016/b978-0-12-462920-2.50016-7.Peer-Reviewed Original Research
1981
Plasma free MHPG and neuroendocrine responses to challenge doses of clonidine in Tourette's Syndrome: Preliminary report
Young J, Cohen D, Hattox S, Kavanagh M, Anderson G, Shaywitz B, Maas J. Plasma free MHPG and neuroendocrine responses to challenge doses of clonidine in Tourette's Syndrome: Preliminary report. Life Sciences 1981, 29: 1467-1475. PMID: 6946271, DOI: 10.1016/0024-3205(81)90012-6.Peer-Reviewed Original ResearchConceptsFree MHPGPlasma free MHPGTourette syndromeChallenge doseNeuroendocrine responsesDoses of clonidineSingle oral dosesClonidine administrationResponsive patientsGH responseOral dosesMaintenance treatmentThyroxine indexClonidineTS patientsPatientsMHPGSyndromeT patientsNeuropsychiatric patientsPilot studyPreliminary reportMetabolic responseFurther investigationDose